Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
Background and Objectives: Real-world evidence of apixaban treatment in patients with chronic kidney disease remains scarce. This study aimed to compare the relative risk of stroke or systemic embolism (SE) and major bleeding between apixaban and warfarin in atrial fibrillation (AF) patients with di...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021-10-01
|
| 叢編: | Frontiers in Cardiovascular Medicine |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.752468/full |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|